Utility of proton pump inhibitors in the treatment of gastrointestinal hemorrhage

Connecticut Medicine

Volumn 68, Issue 7, 2004, Pages 435-438

  Martin, Ralph A ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIMETIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; OCTREOTIDE; OMEPRAZOLE; PANTOPRAZOLE; PLACEBO; PROTON PUMP INHIBITOR; RANITIDINE; SOMATOSTATIN;

DRUG COST; DRUG EFFICACY; DRUG FORMULATION; DRUG USE; GASTROINTESTINAL HEMORRHAGE; HEMOSTASIS; HUMAN; PEPTIC ULCER; PROTON TRANSPORT; RECURRENCE RISK; REVIEW; STOMACH ACID SECRETION; ULCER HEALING; UNITED STATES; UPPER GASTROINTESTINAL BLEEDING;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; BENZIMIDAZOLES; CONNECTICUT; COST-BENEFIT ANALYSIS; ENZYME INHIBITORS; FORMULARIES, HOSPITAL; GASTRIC ACID; GASTROSCOPY; HISTAMINE H2 ANTAGONISTS; HUMANS; OMEPRAZOLE; PEPTIC ULCER HEMORRHAGE; PHARMACY AND THERAPEUTICS COMMITTEE; PROTON PUMPS; SULFOXIDES;

EID: 3843132906     PISSN: 00106178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Laine L, Cohen H, Brodhead J, et al: Prospective evaluation of immediate vs delayed refeeding and prognostic value of endoscopy in patients with upper gastrointestinal hemorrhage. Gastroenterol 1992; 102:314-6.
2. Chen PC, Wu CS, Liau YU: Hemostatic effect of endoscopic local injection with hypertonic saline-epinephrine solution and pure ethanol for digestive tract bleeding. Gastrointest Endosc 1986; 32:319.
3. Panes J, Forne M, Marco C: Controlled trial of endoscopic sclerosis in bleeding peptic ulcers. Lancet 1987; 1:1292.
4. Lin HJ, Chan CY, Lee FY, et al: Endoscopic injection to arrest peptic ulcer hemorrhage: A prospective, randomized controlled trial; preliminary results. Hepatogastroenterol 1991; 38:291.
5. Jung HK, Son HY, Jung SA, et al: Comparison of oral omeprazole and endoscopic ethanol injection therapy for prevention of recurrent bleeding from peptic ulcers with nonbleeding visible vessels or fresh adherent clots. Am J Gastroenterol 2002; 97(7):1736-40.
6. Sung JJ, Chan FK, Lau JY, et al: The effect of endoscopic therapy in patients receiving omeprazole for bleeding ulcers with nonbleeding visible vessels or adherent clots: A randomized comparison. Ann Intern Med 2003; 139:237-243.
7. Terdiman JP, Ostroff JW: Risk of persistent or recurrent and intractable upper gastrointestinal bleeding in the era of therapeutic endoscopy. Am J Gastroenterol 1997; 92:1805-11. [Ovid UI 9382041]
8. Hawkey GM, Cole AT, McIntyre AS, et al: Drug treatments in upper gastrointestinal bleeding: Value of endoscopic findings as surrogate endpoints. Gut 2001; 49(3):372-9.
9. Daneshmend TK, Hawkey CJ, Langman MJS, et al: Omeprazole vs placebo for acute upper gastrointestinal bleeding: Randomised double blind controlled trial. BMJ 1992; 304:143-7.
10. 2 antagonists in acute upper gastrointestinal hemorrhage: Implications of randomized trials. N Engl J Med 1985; 313:660-6.
11. Yamada T, Alpers DH, Kaplowitz N, et al: Eds: Textbook of Gastroenterology. Lippincott Williams & Wilkins. 4th Ed. 2003:703.
12. Michel P, Duhamel C, Basin B, et al: Lansoprazole vs ranitidine in the prevention of early recurrences of digestive hemorrhages from gastroduodenal ulcers. Randomized double-blind multicenter study. [French] Gastroenterol Clin Biol 1994; 18(12):1102-5.
13. Khuroo MS, Yattoo GN, Javid G, et al: A comparison of omeprazole and placebo for bleeding peptic ulcer [comment]. N Engl J Med 1997; 336(15):1054-8.
14. Coraggio F, Rotondano G, Marmo R, et al: Somatostatin in the prevention of recurrent bleeding after endoscopic haemostasis of peptic ulcer haemorrhage: A preliminary report. Eur J Gastroenterol Hepatol 1998; 10(8):673-6.
15. Sofia C, Portela F, Gregorio C, et al: Endoscopic injection therapy vs multipolar electrocoagulation vs laser vs injection + octreotide vs injection + omeprazole in the treatment of bleeding peptic ulcers. A prospective randomized study. Hepatogastroenterol 2000; 47(35):1332-6.
16. Javid G, Masoodi I, Zargar SA, et al: Omeprazole as adjuvant therapy to endoscopic combination injection sclerotherapy for treating bleeding peptic ulcer. Am J Med 2001; 111(4):280-4.
17. Kaviani MJ, Hashemi MR, Kazemifar AR, et al: Effect of oral omeprazole in reducing rebleeding in bleeding peptic ulcers: A prospective, double-blind, randomized, clinical trial. Aliment Pharmacol Ther 2003; 17(2):211-6.
18. Brunner G, Chang J: Intravenous therapy with high doses of ranitidine and omeprazole in critically ill patients with bleeding peptic ulcerations of the upper intestinal tract: An open randomized trial. Digestion 1990; 45:217-25.
19. Perez Flores R: Tratamiento de la hemorragia digestiva alta de origen peptico; Ranitidina intravenosa vs omeprazol intravenoso. Rev Esp Enferm Dig 1994; 86:637-641.
20. Uribarrena R, Bajador E: Omeprazole y cimetinda en el tratemiento de la hemorragia digestiva alta. Rev Esp Enferm Dig 1994; 86:879-83.
21. Goletti O, Sidoti F, Lippolis PV, et al: Omeprazole vs ranitidine plus somatostatin in the treatment of severe gastroduodenal bleeding: A prospective, randomized, controlled trial. Ital J Gastroenterol 1994; 26:72-4.
22. Orti E, Canelles P: Afecta a la evolucion de la hemorragia digestiva alta el antisecretor utilizado? Rev Esp Enferm Dig 1995; 87:427-30.
23. Lanas A, Artal A, Blas J, et al: Effect of parenteral omeprazole and ranitidine on gastric pH and the outcome of bleeding peptic ulcer. J Clin Gastroenterol 1995; 21:103-106.
24. Lind T, Aadland E, Eriksson S, et al: Beneficial effects of IV omeprazole in patients with peptic ulcer bleeding. Abstr. Gastroenterol 1995; 108:A150
25. Cardi M, Muttillo IA: Omeprazole vs ranitidine ontraveineux dans le traitement de l'ulcere duodenal hemorragique: Une etude randomisee prospective. Ann Chir 1997; 51:136-9.
26. Prassler R, Hendrich H: Sind Protonenpumpenhemmer nach endoskopischer Stillung der akuten Ulcusblutung gegenuber H2-Rezeptorantagonisten von Vorteil? Z Gastroenterol 1995; 33:431-4.
27. Villanueva C, Balanzo J, Torras X, et al: Omeprazole versus ranitidine as adjunct therapy to endoscopic injection in actively bleeding ulcers: A prospective and randomized study. Endoscopy 1995; 27:308-12
28. Schaffalitzky de Muckadell OB, Havelund T, Harling H, et al: Effect of omeprazole on the outcome of endoscopically treated bleeding peptic ulcers. Scand J Gastroenterol 1997; 32:320-7.
29. Hasselgren G, Lind T, Lundell L, et al: Continuous intravenous infusion of omeprazole in elderly patients with peptic ulcer bleeding: Results of a placebo-controlled multicenter study. Scand J Gastroenterol 1997; 32:328-33.
30. Lin HJ, Lo WC, Lee FY, et al: A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy. Arch Intern Med 1998; 158:54-8.
31. Lau JYW, Sung JJY, Lee KKC, et al: Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med 2000; 343:310-16.